Dr. Sucharita Boddu, MD

Dr. Boddu practices at Sharp Rees-Stealy Medical Group, Inc in San Diego, California.

Dr. Boddu's NPI, 1679968705, was assigned on April 6, 2015. Dr. Boddu graduated from New York University School of Medicine in 2015. Dr. Boddu's California license number on file is A151938.

Dr. Boddu's primary practice is Sharp Rees-Stealy Medical Group, Inc, at 5651 Copley Dr, San Diego, CA 92111 in San Diego County. The practice phone is (858) 262-6666.

Dr. Boddu's primary practice is Sharp Rees-Stealy Medical Group, Inc in San Diego, California. The medical group on file is Sharp Rees-Stealy Medical Group. Dmand AI also links Dr. Boddu to 1 more physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Boddu practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Boddu's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Boddu is board certified in dermatology by the American Board of Dermatology. Dr. Boddu has a license on file in California.

Dmand AI lists acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, contact dermatitis, facial skin infection, itchy rashes, joint cyst and minor injury to a limb among the conditions Dr. Boddu treats.

CMS data shows 1,392 Medicare services from Dr. Boddu across 14 procedure codes in 2023. Medicare paid $56,437 for them. Every service was in an office.

Across all payers, Dmand AI patient panel data puts Dr. Boddu's median patient age at 58, with 66% women.

In 2024, Dr. Boddu wrote 20 Medicare Part D claims for 12 patients. 95% of them were for generic drugs. They cover 4 drugs, with $1,357 in total drug cost. In 2022, CMS named 35 claims across 2 drugs.

Dr. Boddu accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 245 procedures of removal of skin lesions by Dr. Boddu, more than 81% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 17 papers to Dr. Boddu, published from 2013 to 2022. 2014 was the busiest year, with 3. The most frequent topics are Tomography, Optical Coherence, Angiogenesis Inhibitors and Fluorescein Angiography. Dr. Boddu has published most often in Am J Ophthalmol. Dr. Boddu's most frequent co-authors are Jesse J. Jung, MD, Emanual Michael Maverakis, MD and Stephanie T. Le, MD.

CMS Open Payments shows 124 general payments to Dr. Boddu from 21 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 74% of the total. Allergan Inc. paid the most, $1,396.

Dr. Boddu graduated from New York University School of Medicine in 2015.

Dr. Boddu is in network with 9 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 6. Check the plan with the practice before a visit.